Martina Towers

ORCID: 0000-0001-8919-0792
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • interferon and immune responses
  • Redox biology and oxidative stress
  • Immune Cell Function and Interaction
  • RNA Research and Splicing
  • Galectins and Cancer Biology
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Cancer Mechanisms and Therapy
  • RNA regulation and disease
  • MicroRNA in disease regulation
  • Ferroptosis and cancer prognosis
  • Circadian rhythm and melatonin
  • Immunotherapy and Immune Responses
  • CRISPR and Genetic Engineering
  • Chromatin Remodeling and Cancer
  • Influenza Virus Research Studies
  • Circular RNAs in diseases

The University of Texas MD Anderson Cancer Center
2023-2024

The Wistar Institute
2022-2023

Abstract Aberrant glycosylation is a crucial strategy employed by cancer cells to evade cellular immunity. However, it’s unclear whether homologous recombination (HR) status-dependent can be therapeutically explored. Here, we show that the inhibition of branched N -glycans sensitizes HR-proficient, but not HR-deficient, epithelial ovarian cancers (EOCs) immune checkpoint blockade (ICB). In contrast fucosylation whose EOCs anti-PD-L1 immunotherapy regardless HR-status, observe an enrichment...

10.1038/s41467-024-47069-y article EN cc-by Nature Communications 2024-04-02

We have previously demonstrated that the circadian clock regulates host response to influenza A virus (IAV) infection, conferring a time-of-day-specific protection; infection at dawn resulted in threefold increase survival and reduced immunopathology compared dusk. While IL–10 is well-known for its immunoregulatory function, role IAV remains unclear, with studies reporting both protective detrimental effects. Given diurnal rhythmicity of receptor (Il10ra) expression lung, we investigated...

10.1101/2025.03.03.641134 preprint EN 2025-03-10

Abstract Introduction: Epithelial Ovarian cancer (EOC) is one of the most fatal gynecological malignancies, with little improvement being made to early-stage diagnostics or treatment options over years. The standard care for EOC remains be platinum-based chemotherapy despite ultimate relapse which arises acquired chemoresistance. Accumulating studies show that stem-like cells (CSCs) following initial platinum contribute developed chemoresistance and metastasis. Thus, there an urgent need...

10.1158/1538-7445.ovarian23-b029 article EN Cancer Research 2024-03-04

Abstract Cellular senescence regulates cancer and tissue aging in part through the secretion of proinflammatory factors known as senescence-associated secretory phenotype (SASP). For example, sterile inflammation or ‘inflammaging’ is a hallmark aging. Thioredoxin reductase 1 (TXNRD1) genetic variability associated with often upregulated human cancers. TXNRD1’s role regulating has been attributed to its enzymatic cellular redox. Here we show that TXNRD1 drives SASP cyclic GMP-AMP synthase...

10.1158/1538-7445.agca22-pr011 article EN Cancer Research 2023-01-15
Coming Soon ...